Conversely, reduced hepatic lipid synthesis was observed by decreasing sterol regulatory element-binding protein 1c (SREBP-1c) and fatty acid synthase (FASN), suggesting an anti-obesity and cardioprotective effect (18). This evidence concerns the gene FASN and obesity disorder.